136 related articles for article (PubMed ID: 37110589)
21. Synthesis and evaluation of antiplatelet activity of trihydroxychalcone derivatives.
Zhao LM; Jin HS; Sun LP; Piao HR; Quan ZS
Bioorg Med Chem Lett; 2005 Nov; 15(22):5027-9. PubMed ID: 16169724
[TBL] [Abstract][Full Text] [Related]
22. Antiplatelet activity of BRX-018, (6aS,cis)-malonic acid 3-acetoxy-6a9-bis-(2-methoxycarbonyl-acetoxy)-6,6a,7,11b-tetrahydro-indeno[2,1-c]chromen-10-yl ester methylester.
Lee GY; Chang TS; Lee KS; Khil LY; Kim D; Chung JH; Kim YC; Lee BH; Moon CH; Moon CK
Thromb Res; 2005; 115(4):309-18. PubMed ID: 15668191
[TBL] [Abstract][Full Text] [Related]
23. [The effects of ligustrazine, aspirin and beta-histine on platelet aggregation in patients with acute ischemic stroke].
Gao BT
Zhonghua Shen Jing Jing Shen Ke Za Zhi; 1989 Jun; 22(3):148-51, 191. PubMed ID: 2591268
[TBL] [Abstract][Full Text] [Related]
24. The Synergistic Effect of
Ke J; Li MT; Huo YJ; Cheng YQ; Guo SF; Wu Y; Zhang L; Ma J; Liu AJ; Han Y
Drug Des Devel Ther; 2021; 15():3543-3560. PubMed ID: 34429584
[TBL] [Abstract][Full Text] [Related]
25. Synthesis, nitric oxide release, and dipeptidyl peptidase-4 inhibition of sitagliptin derivatives as new multifunctional antidiabetic agents.
Xie Y; Shao L; Wang Q; Bai Y; Chen Z; Li N; Xu Y; Li Y; Yang G; Bian X
Bioorg Med Chem Lett; 2018 Dec; 28(23-24):3731-3735. PubMed ID: 30343953
[TBL] [Abstract][Full Text] [Related]
26. 9-(4'-dimethylaminophenyl)-2,6,7-trihydroxy-xanthene-3-one is a Potentially Novel Antiplatelet Drug which Antagonizes the Effect of Thromboxane A2.
Applova L; Veljovic E; Muratovic S; Karlickova J; Macakova K; Zavrsnik D; Saso L; Duric K; Mladenka P
Med Chem; 2018 Feb; 14(2):200-209. PubMed ID: 29032760
[TBL] [Abstract][Full Text] [Related]
27. [Synthesis and antiplatelet activity of 2-amino-4,5-diphenylthiazole derivatives].
Inoue H; Ikesue K; Taniguchi Y
Yakugaku Zasshi; 1995 Aug; 115(8):603-10. PubMed ID: 7473057
[TBL] [Abstract][Full Text] [Related]
28. Design, synthesis, and biological evaluation of ligustrazine/resveratrol hybrids as potential anti-ischemic stroke agents.
Zhang YQ; Wu JB; Yin W; Zhang YH; Huang ZJ
Chin J Nat Med; 2020 Aug; 18(8):633-640. PubMed ID: 32768171
[TBL] [Abstract][Full Text] [Related]
29. Platelet antiaggregating activity of ginsenosides isolated from processed ginseng.
Lee JG; Lee YY; Kim SY; Pyo JS; Yun-Choi HS; Park JH
Pharmazie; 2009 Sep; 64(9):602-4. PubMed ID: 19827304
[TBL] [Abstract][Full Text] [Related]
30. Antiplatelet aggregation activity of diterpene alkaloids from Spiraea japonica.
Li L; Shen YM; Yang XS; Zuo GY; Shen ZQ; Chen ZH; Hao XJ
Eur J Pharmacol; 2002 Aug; 449(1-2):23-8. PubMed ID: 12163102
[TBL] [Abstract][Full Text] [Related]
31. Synthesis, antiplatelet and antithrombotic activities of resveratrol derivatives with NO-donor properties.
Dutra LA; Guanaes JFO; Johmann N; Lopes Pires ME; Chin CM; Marcondes S; Dos Santos JL
Bioorg Med Chem Lett; 2017 Jun; 27(11):2450-2453. PubMed ID: 28400236
[TBL] [Abstract][Full Text] [Related]
32. One pot synthesis and biological activity evaluation of novel Schiff bases derived from 2-hydrazinyl-1,3,4-thiadiazole.
Haj Mohammad Ebrahim Tehrani K; Sardari S; Mashayekhi V; Esfahani Zadeh M; Azerang P; Kobarfard F
Chem Pharm Bull (Tokyo); 2013; 61(2):160-6. PubMed ID: 23183543
[TBL] [Abstract][Full Text] [Related]
33. Synthesis and antiplatelet activity of some 2,7-di(N-cycloamino)-3-phenyl-1,8-naphthyridine derivatives.
Ferrarini PL; Badawneh M; Franconi F; Manera C; Miceli M; Mori C; Saccomanni G
Farmaco; 2001 Apr; 56(4):311-8. PubMed ID: 11421260
[TBL] [Abstract][Full Text] [Related]
34. Effects of chroman derivatives on platelet aggregation induced by some aggregating agents in rabbits.
Aida Y; Kasama T; Fukaya H; Takeuchi N; Sugiyama K; Tobinaga S
Clin Exp Pharmacol Physiol; 1998 Nov; 25(11):939-44. PubMed ID: 9807668
[TBL] [Abstract][Full Text] [Related]
35. Synthesis and antiplatelet effects of omega-aminoalkoxylxanthones.
Lin CN; Liou SS; Lai SC; Lin HC; Ko FN; Liu HW; Teng CM
J Pharm Pharmacol; 1995 Jul; 47(7):588-94. PubMed ID: 8568627
[TBL] [Abstract][Full Text] [Related]
36. Inhibition of arachidonic acid induced-aggregation of rabbit platelets with CV-4151 (isbogrel), a selective thromboxane A2 (TXA2) synthase inhibitor: modulation of the antiplatelet action and prostanoid metabolism by rat aortic rings.
Terashita Z; Imura Y; Nishikawa K
J Lipid Mediat Cell Signal; 1996 Jan; 13(1):1-8. PubMed ID: 8821806
[TBL] [Abstract][Full Text] [Related]
37. New pyrazolylhydrazone derivatives as inhibitors of platelet aggregation.
da Silveira IA; Paulo LG; de Miranda AL; Rocha SO; Freitas AC; Barreiro EJ
J Pharm Pharmacol; 1993 Jul; 45(7):646-9. PubMed ID: 8105062
[TBL] [Abstract][Full Text] [Related]
38. Anti-platelet aggregation activity of some pyrazines.
Ohta A; Takahashi H; Miyata N; Hirono H; Nishio T; Uchino E; Yamada K; Aoyagi Y; Suwabe Y; Fujitake M; Suzuki T; Okamoto K
Biol Pharm Bull; 1997 Oct; 20(10):1076-81. PubMed ID: 9353568
[TBL] [Abstract][Full Text] [Related]
39. Comparison of antiplatelet effects of two nitric oxide-donating agents, FR146801 and FK409.
Hirasawa Y; Kato Y; Fukuyama S; Ohno M; Nishino S; Kato M; Kita Y
Thromb Haemost; 1998 Mar; 79(3):620-4. PubMed ID: 9531052
[TBL] [Abstract][Full Text] [Related]
40. Influence of vitamin E on the antiplatelet effect of acetylsalicylic acid in human blood.
González-Correa JA; Arrebola MM; Guerrero A; Muñoz-Marín J; Ruiz-Villafranca D; Sánchez de La Cuesta F; De La Cruz JP
Platelets; 2005; 16(3-4):171-9. PubMed ID: 16011961
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
